nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—CYP3A4—Esomeprazole—Barrett's esophagus	0.269	0.389	CbGbCtD
Clofazimine—ABCB1—Omeprazole—Barrett's esophagus	0.265	0.382	CbGbCtD
Clofazimine—CYP3A4—Omeprazole—Barrett's esophagus	0.159	0.229	CbGbCtD
Clofazimine—ABCB11—bile—Barrett's esophagus	0.0889	0.845	CbGeAlD
Clofazimine—Epigastric pain—Omeprazole—Barrett's esophagus	0.0121	0.0605	CcSEcCtD
Clofazimine—Epigastric pain—Esomeprazole—Barrett's esophagus	0.0121	0.0605	CcSEcCtD
Clofazimine—Visual acuity reduced—Esomeprazole—Barrett's esophagus	0.00979	0.0492	CcSEcCtD
Clofazimine—Visual acuity reduced—Omeprazole—Barrett's esophagus	0.00979	0.0492	CcSEcCtD
Clofazimine—ABCB11—digestive system—Barrett's esophagus	0.00971	0.0923	CbGeAlD
Clofazimine—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00569	0.0286	CcSEcCtD
Clofazimine—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00569	0.0286	CcSEcCtD
Clofazimine—Cystitis—Esomeprazole—Barrett's esophagus	0.00563	0.0282	CcSEcCtD
Clofazimine—Cystitis—Omeprazole—Barrett's esophagus	0.00563	0.0282	CcSEcCtD
Clofazimine—Bladder pain—Esomeprazole—Barrett's esophagus	0.00527	0.0264	CcSEcCtD
Clofazimine—Bladder pain—Omeprazole—Barrett's esophagus	0.00527	0.0264	CcSEcCtD
Clofazimine—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.00496	0.0249	CcSEcCtD
Clofazimine—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.00496	0.0249	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00423	0.0212	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00423	0.0212	CcSEcCtD
Clofazimine—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00386	0.0194	CcSEcCtD
Clofazimine—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00386	0.0194	CcSEcCtD
Clofazimine—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00385	0.0193	CcSEcCtD
Clofazimine—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00385	0.0193	CcSEcCtD
Clofazimine—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00334	0.0167	CcSEcCtD
Clofazimine—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00334	0.0167	CcSEcCtD
Clofazimine—Weight decreased—Esomeprazole—Barrett's esophagus	0.00331	0.0166	CcSEcCtD
Clofazimine—Weight decreased—Omeprazole—Barrett's esophagus	0.00331	0.0166	CcSEcCtD
Clofazimine—Depression—Omeprazole—Barrett's esophagus	0.00325	0.0163	CcSEcCtD
Clofazimine—Depression—Esomeprazole—Barrett's esophagus	0.00325	0.0163	CcSEcCtD
Clofazimine—Jaundice—Esomeprazole—Barrett's esophagus	0.00318	0.0159	CcSEcCtD
Clofazimine—Jaundice—Omeprazole—Barrett's esophagus	0.00318	0.0159	CcSEcCtD
Clofazimine—Hepatitis—Esomeprazole—Barrett's esophagus	0.00293	0.0147	CcSEcCtD
Clofazimine—Hepatitis—Omeprazole—Barrett's esophagus	0.00293	0.0147	CcSEcCtD
Clofazimine—Visual impairment—Esomeprazole—Barrett's esophagus	0.00282	0.0142	CcSEcCtD
Clofazimine—Visual impairment—Omeprazole—Barrett's esophagus	0.00282	0.0142	CcSEcCtD
Clofazimine—CYP3A4—digestive system—Barrett's esophagus	0.00251	0.0238	CbGeAlD
Clofazimine—Anaemia—Omeprazole—Barrett's esophagus	0.00235	0.0118	CcSEcCtD
Clofazimine—Anaemia—Esomeprazole—Barrett's esophagus	0.00235	0.0118	CcSEcCtD
Clofazimine—ABCB1—epithelium—Barrett's esophagus	0.00233	0.0222	CbGeAlD
Clofazimine—Anorexia—Esomeprazole—Barrett's esophagus	0.00198	0.00995	CcSEcCtD
Clofazimine—Anorexia—Omeprazole—Barrett's esophagus	0.00198	0.00995	CcSEcCtD
Clofazimine—Somnolence—Omeprazole—Barrett's esophagus	0.00185	0.00928	CcSEcCtD
Clofazimine—Somnolence—Esomeprazole—Barrett's esophagus	0.00185	0.00928	CcSEcCtD
Clofazimine—Decreased appetite—Omeprazole—Barrett's esophagus	0.00181	0.00907	CcSEcCtD
Clofazimine—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00181	0.00907	CcSEcCtD
Clofazimine—Fatigue—Esomeprazole—Barrett's esophagus	0.00179	0.009	CcSEcCtD
Clofazimine—Fatigue—Omeprazole—Barrett's esophagus	0.00179	0.009	CcSEcCtD
Clofazimine—Constipation—Omeprazole—Barrett's esophagus	0.00178	0.00892	CcSEcCtD
Clofazimine—Constipation—Esomeprazole—Barrett's esophagus	0.00178	0.00892	CcSEcCtD
Clofazimine—ABCB1—digestive system—Barrett's esophagus	0.00178	0.0169	CbGeAlD
Clofazimine—Body temperature increased—Omeprazole—Barrett's esophagus	0.00164	0.00825	CcSEcCtD
Clofazimine—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00164	0.00825	CcSEcCtD
Clofazimine—Asthenia—Omeprazole—Barrett's esophagus	0.00149	0.00749	CcSEcCtD
Clofazimine—Asthenia—Esomeprazole—Barrett's esophagus	0.00149	0.00749	CcSEcCtD
Clofazimine—Pruritus—Esomeprazole—Barrett's esophagus	0.00147	0.00738	CcSEcCtD
Clofazimine—Pruritus—Omeprazole—Barrett's esophagus	0.00147	0.00738	CcSEcCtD
Clofazimine—Diarrhoea—Omeprazole—Barrett's esophagus	0.00142	0.00714	CcSEcCtD
Clofazimine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00142	0.00714	CcSEcCtD
Clofazimine—Dizziness—Omeprazole—Barrett's esophagus	0.00137	0.0069	CcSEcCtD
Clofazimine—Dizziness—Esomeprazole—Barrett's esophagus	0.00137	0.0069	CcSEcCtD
Clofazimine—Vomiting—Omeprazole—Barrett's esophagus	0.00132	0.00663	CcSEcCtD
Clofazimine—Vomiting—Esomeprazole—Barrett's esophagus	0.00132	0.00663	CcSEcCtD
Clofazimine—Rash—Esomeprazole—Barrett's esophagus	0.00131	0.00658	CcSEcCtD
Clofazimine—Rash—Omeprazole—Barrett's esophagus	0.00131	0.00658	CcSEcCtD
Clofazimine—Dermatitis—Omeprazole—Barrett's esophagus	0.00131	0.00657	CcSEcCtD
Clofazimine—Dermatitis—Esomeprazole—Barrett's esophagus	0.00131	0.00657	CcSEcCtD
Clofazimine—Headache—Esomeprazole—Barrett's esophagus	0.0013	0.00654	CcSEcCtD
Clofazimine—Headache—Omeprazole—Barrett's esophagus	0.0013	0.00654	CcSEcCtD
Clofazimine—Nausea—Esomeprazole—Barrett's esophagus	0.00123	0.0062	CcSEcCtD
Clofazimine—Nausea—Omeprazole—Barrett's esophagus	0.00123	0.0062	CcSEcCtD
Clofazimine—ABCB11—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000492	0.219	CbGpPWpGaD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000283	0.126	CbGpPWpGaD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000283	0.126	CbGpPWpGaD
Clofazimine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000176	0.0781	CbGpPWpGaD
Clofazimine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000108	0.0481	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000101	0.0449	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000101	0.0449	CbGpPWpGaD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.31e-05	0.0413	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	6.5e-05	0.0289	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	6.23e-05	0.0277	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	6.23e-05	0.0277	CbGpPWpGaD
Clofazimine—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	4.32e-05	0.0192	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	3.95e-05	0.0176	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	3.92e-05	0.0174	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	3.9e-05	0.0173	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	3.33e-05	0.0148	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	3.2e-05	0.0142	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	2.05e-05	0.0091	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PTGES—Barrett's esophagus	1.74e-05	0.00775	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	1.7e-05	0.00756	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	1.68e-05	0.00746	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP26A1—Barrett's esophagus	1.32e-05	0.00587	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	1.29e-05	0.00574	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	1.19e-05	0.00527	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	9.77e-06	0.00434	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—SLC9A1—Barrett's esophagus	9.53e-06	0.00423	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	8.66e-06	0.00385	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	7.68e-06	0.00341	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	7.27e-06	0.00323	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	6.58e-06	0.00292	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PTGES—Barrett's esophagus	6.23e-06	0.00277	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	4.73e-06	0.0021	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PPARG—Barrett's esophagus	4.35e-06	0.00193	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.91e-06	0.00174	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.84e-06	0.00171	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PTGS2—Barrett's esophagus	3.42e-06	0.00152	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	3.41e-06	0.00151	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.91e-06	0.00129	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	2.1e-06	0.000932	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.55e-06	0.00069	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.22e-06	0.000543	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PPARG—Barrett's esophagus	9.58e-07	0.000425	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	7.54e-07	0.000335	CbGpPWpGaD
